Merck is leveraging generative AI and AWS technology to enhance its research and manufacturing processes, ensuring faster access to life-saving medicines. By utilizing Amazon S3 and Redshift, Merck has built advanced analytics tools that provide end-to-end visibility across its value chain. This innovation has significantly reduced false rejection rates by over 80% and accelerated investigation times from weeks to mere seconds. With AWS’s comprehensive hosting and analytical capabilities, Merck is transforming drug development, optimizing production, and delivering critical medicines to patients faster than ever.
Subscribe to AWS: https://go.aws/subscribe
Sign up for AWS: https://go.aws/signup
AWS free tier: https://go.aws/free
Explore more: https://go.aws/more
Contact AWS: https://go.aws/contact
Next steps:
Explore on AWS in Analyst Research: https://go.aws/reports
Discover, deploy, and manage software that runs on AWS: https://go.aws/marketplace
Join the AWS Partner Network: https://go.aws/partners
Learn more on how Amazon builds and operates software: https://go.aws/library
Do you have technical AWS questions?
Ask the community of experts on AWS re:Post: https://go.aws/3lPaoPb
Why AWS?
Amazon Web Services (AWS) is the world’s most comprehensive and broadly adopted cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—use AWS to be more agile, lower costs, and innovate faster.
#AWS #AmazonWebServices #CloudComputing #AWSforLifeSciences #LifeSciences #AgenticAI #generativeAI
